XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
November 10, 2008 08:01 ET
|
XOMA Corporation
BERKELEY, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the restructuring of its product...
XOMA Appoints Steve Doberstein to Vice President of Research
October 28, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 28, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced the appointment of Stephen K....
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
October 25, 2008 20:00 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 25, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced that its poster titled "Efficacy Of...
XOMA to Present At the BIO Investor Forum On October 30
October 23, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 23, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, XOMA's Chairman and...
XOMA Enters Into $60 Million Committed Equity Financing Facility
October 22, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Oct. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that it has entered into a committed equity financing facility under which it has the option to sell up to...
XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25
September 22, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 22, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that the company will host a live web...
XOMA to Present At the UBS Global Life Sciences Conference On September 22
September 16, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
New Programs Added in Antibody Collaboration Between XOMA and Takeda
September 15, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the initiation of new therapeutic...
Texas A&M University System and XOMA Sign Memorandum of Understanding
September 10, 2008 16:35 ET
|
XOMA Corporation
COLLEGE STATION, Texas and BERKELEY, Calif., Sept. 10, 2008 (GLOBE NEWSWIRE) -- The Texas A&M University System and XOMA, Ltd (Nasdaq:XOMA), a leader in the discovery and development of...
XOMA Awarded $65 Million Biodefense Contract by NIAID to Advance Drug Candidates Against Botulism Toxins Into Clinical Trials
September 09, 2008 13:57 ET
|
XOMA Corporation
BERKELEY, Calif., Sept. 9, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced that it was awarded a $65 million multiple year contract from the National Institute of Allergy and...